US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 22:03:52 Source：Stellar Stories news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Brazil replaces injured goalkeeper Ederson in Copa America squad
- Next：Digital technologies restore looks of 2,200
Related articles
- NBA playoffs: Edwards leads Wolves to 98
- How Princess Diana's audacious bid for freedom 30 years ago became a heart
- China news: Solomon Islands strikes $95 million Huawei internet deal
- Dozens of jobs set to be axed at Treasury
- Sale continues dominant run as Braves beat Padres 3
- A quiet birthday for Meghan's former best
- China news: Solomon Islands strikes $95 million Huawei internet deal
- Never leave a man behind: Veterans join forces to give British spy a proper send
- Amir Khan's £11.5m luxury wedding venue finally hosts its first marriage: Bride arrives on horse
- New US inflation data 'along the lines' of what Fed wants, Powell says
- Target to lower prices on basic goods in response to inflation
- Norway's Arctic north wants to bring in a 26
- JAN MOIR: Why JK Rowling SHOULDN'T forgive the weaselly band
- US House passes controversial surveillance bill on 4th attempt
- Rays opening
- Lady Tatiana Mountbatten
- Mother, 24, outraged after learning shopping centre bathroom with baby changing facilities has CCTV
- US, UK intelligence leaders raise fresh alarms about Chinese espionage
- Celebrity tequila brands, like George Clooney
- Listen up: Northland to test tsunami sirens
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Stellar Stories news portal sitemap